Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain and complication comparison of Dysport and Xeomin diluted with lidocaine or normal saline for cosmetic facial injections
IRCT20210401050804N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A and lidocaine (3 arms), sponsored by Islamic Azad University. Primary endpoints: Pain, Ptosis and 2 more. Started Apr 2021; status: completed.
02
Drugs
botulinum toxin type Alidocaine
Beyond the preview
Go deeper on IRCT20210401050804N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210401050804N1.